Brown Shipley& Co Ltd Decreases Stock Position in CME Group Inc. (NASDAQ:CME)

Brown Shipley& Co Ltd trimmed its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 1.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,302 shares of the financial services provider’s stock after selling 74 shares during the quarter. CME Group makes up [...]

featured-image

Brown Shipley& Co Ltd trimmed its position in shares of CME Group Inc. ( NASDAQ:CME – Free Report ) by 1.0% in the 2nd quarter, according to its most recent disclosure with the SEC.

The institutional investor owned 7,302 shares of the financial services provider’s stock after selling 74 shares during the quarter. CME Group makes up approximately 0.6% of Brown Shipley& Co Ltd’s investment portfolio, making the stock its 24th largest position.



Brown Shipley& Co Ltd’s holdings in CME Group were worth $1,436,000 at the end of the most recent quarter. Several other hedge funds have also recently added to or reduced their stakes in CME. Salomon & Ludwin LLC acquired a new position in shares of CME Group during the 1st quarter valued at about $28,000.

Y.D. More Investments Ltd purchased a new stake in shares of CME Group in the 2nd quarter valued at approximately $36,000.

Rise Advisors LLC acquired a new stake in shares of CME Group during the 1st quarter worth approximately $41,000. McClarren Financial Advisors Inc. raised its position in shares of CME Group by 66.

1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the period.

Finally, Asset Dedication LLC lifted its holdings in CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares during the last quarter.

87.75% of the stock is owned by institutional investors and hedge funds. CME Group Stock Performance Shares of CME opened at $218.

30 on Monday. The company has a market capitalization of $78.60 billion, a price-to-earnings ratio of 24.

84, a price-to-earnings-growth ratio of 8.74 and a beta of 0.55.

CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.

80. The company has a quick ratio of 1.02, a current ratio of 1.

02 and a debt-to-equity ratio of 0.10. The stock has a 50 day moving average price of $209.

70 and a 200 day moving average price of $207.41. CME Group Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th.

Stockholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th.

This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.11%.

CME Group’s payout ratio is 52.33%. Insider Activity at CME Group In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th.

The shares were sold at an average price of $216.99, for a total transaction of $163,610.46.

Following the completion of the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link .

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.

59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.

13. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link . Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th.

The stock was sold at an average price of $216.99, for a total transaction of $163,610.46.

Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here .

0.30% of the stock is owned by insiders. Analyst Ratings Changes A number of equities research analysts have commented on the company.

TD Cowen started coverage on CME Group in a research report on Thursday. They issued a “hold” rating and a $221.00 target price on the stock.

Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th.

Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th.

Barclays boosted their price target on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research note on Thursday, July 25th.

Finally, Bank of America downgraded shares of CME Group from a “neutral” rating to an “underperform” rating and dropped their target price for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd.

Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $212.54.

Check Out Our Latest Report on CME Group CME Group Company Profile ( Free Report ) CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. Recommended Stories Five stocks we like better than CME Group Using the MarketBeat Stock Split Calculator 3 Bargain Stocks Under $20 With Major Growth Potential 3 Small Caps With Big Return Potential Top 5 ETFs to Own Now and Into 2025 What is the Dogs of the Dow Strategy? Overview and Examples Watch These 3 Former Short-Squeeze Stocks for a Big Rally Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.

com's FREE daily email newsletter ..